Spots Global Cancer Trial Database for lymphoblastic leukemia
Every month we try and update this database with for lymphoblastic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) | NCT00500240 | Leukemia Lymphoma | Insulin Glargin... Insulin Aspart | 15 Years - | M.D. Anderson Cancer Center | |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | NCT03564704 | Leukemia Leukemia, Acute Adult Lymphobla... Leukemia, Lymph... Leukemia, T Cel... Adult Acute Lym... Lymphoblastic L... Lymphoblastic L... | Dexamethasone vincristine Cyclophosphamid... Idarubicin Pegaspargase Adriamycin Methotrexate 6-mercaptopurin... Etoposide Cytarabine Bone marrow asp... Intrathecal inj... Radiation thera... NGS allogeneic hema... Flow-MRD FISH Flow immunophen... Karyotyping Chidamide PET-CT scan | 14 Years - 55 Years | Nanfang Hospital, Southern Medical University | |
| Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia | NCT05993949 | Lymphoblastic L... | Dasatinib | 18 Years - | Stanford University | |
| Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia | NCT01615809 | Invasive Pulmon... Lymphoblastic L... Myeloblastic Le... Lymphoblastic L... Myeloblastic Le... | AMPHOTERICIN B | 3 Years - 17 Years | Fundació Sant Joan de Déu | |
| Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor | NCT00967343 | Myeloid Leukemi... Lymphoblastic L... Lymphoma Multiple Myelom... Myelodysplastic... Myeloproliferat... | Donor lymphocyt... | 18 Years - 65 Years | Kiadis Pharma | |
| Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus | NCT00133367 | Multiple Myelom... Non-Hodgkin's L... Hodgkin's Disea... Myelogenous Leu... Lymphoblastic L... | Tacrolimus Sirolimus G-CSF Antithymocyte g... Thymoglobulin Fludarabine Melphalan | 18 Years - 65 Years | Massachusetts General Hospital | |
| Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor | NCT00967343 | Myeloid Leukemi... Lymphoblastic L... Lymphoma Multiple Myelom... Myelodysplastic... Myeloproliferat... | Donor lymphocyt... | 18 Years - 65 Years | Kiadis Pharma | |
| Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in Pediatrics | NCT05664230 | Lymphoblastic L... | osteopathy | 1 Year - 10 Years | Assistance Publique - Hôpitaux de Paris | |
| Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors | NCT05194397 | Lymphoblastic L... Cancer Survivor... Aplastic Anemia Myelodysplastic... | Nicotinamide Ri... Placebo Exercise Interv... | 10 Years - 30 Years | Children's Hospital of Philadelphia | |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | NCT03328104 | Lymphoblastic L... Lymphoblastic L... | Everolimus Nelarabine Cyclophosphamid... Etoposide | 2 Years - 29 Years | Emory University | |
| CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia | NCT05043571 | Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... CAR CAR T-Cell-Rela... Refractory Leuk... | CAR T-cell ther... | 6 Months - 65 Years | National University Hospital, Singapore | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease | NCT01174940 | Stem Cell Leuke... Graft Versus Ho... | extracorporeal ... | 18 Years - | University of Kansas Medical Center | |
| Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant | NCT00354120 | Acute Myeloblas... Lymphoblastic L... Myelodysplasia Chronic Myeloid... Myelofibrosis Lympho-prolifer... | Alentuzumab Globulina antil... | 18 Years - 65 Years | Gruppo Italiano Trapianto di Midollo Osseo | |
| Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in Pediatrics | NCT05664230 | Lymphoblastic L... | osteopathy | 1 Year - 10 Years | Assistance Publique - Hôpitaux de Paris | |
| Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease | NCT01174940 | Stem Cell Leuke... Graft Versus Ho... | extracorporeal ... | 18 Years - | University of Kansas Medical Center | |
| Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma | NCT00388531 | Lymphoblastic L... Lymphoma | Depocyte® | 18 Years - | PETHEMA Foundation | |
| Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma | NCT02043587 | Acute Lymphocyt... Adult Lymphobla... | DNR VCR PEG-asp CTX Prednisone Liposomal AraC MTX LCV AraC Etoposide Dasatinib Rituximab Hydrocortisone | 18 Years - 60 Years | University of California, San Diego | |
| An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) | NCT04145531 | Acute Lymphobla... Lymphoblastic L... | IM JZP-458 IV JZP-458 | - | Jazz Pharmaceuticals | |
| Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL | NCT06175702 | Lymphoblastic L... Philadelphia-Po... Adult ALL | Vincristine Dexamethasone Imatinib Cytarabine Mercaptopurine Methotrexate Ponatinib allogeneic stem... Total body irra... Cyclophosphamid... Fludarabine | 18 Years - | PETHEMA Foundation | |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | NCT03328104 | Lymphoblastic L... Lymphoblastic L... | Everolimus Nelarabine Cyclophosphamid... Etoposide | 2 Years - 29 Years | Emory University | |
| Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) | NCT01520922 | Chronic Lymphoc... Leukaemia, Lymp... | Ofatumumab Bendamustine | 18 Years - | Novartis | |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) | NCT00500240 | Leukemia Lymphoma | Insulin Glargin... Insulin Aspart | 15 Years - | M.D. Anderson Cancer Center | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease | NCT01174940 | Stem Cell Leuke... Graft Versus Ho... | extracorporeal ... | 18 Years - | University of Kansas Medical Center | |
| Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) | NCT01520922 | Chronic Lymphoc... Leukaemia, Lymp... | Ofatumumab Bendamustine | 18 Years - | Novartis | |
| Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma | NCT00866749 | Lymphoblastic L... Lymphoblastic L... | Daunorubicin Vincristine PEG-asparaginas... Intrathecal Met... Cyclophosphamid... Cytarabine Mercaptopurine Methotrexate Doxorubicin Thioguanine | 12 Years - 40 Years | M.D. Anderson Cancer Center | |
| Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | NCT03328104 | Lymphoblastic L... Lymphoblastic L... | Everolimus Nelarabine Cyclophosphamid... Etoposide | 2 Years - 29 Years | Emory University | |
| Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia | NCT05993949 | Lymphoblastic L... | Dasatinib | 18 Years - | Stanford University | |
| Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia | NCT01116193 | Leukemia, Lymph... Precursor B-Cel... | Lenalidomide pl... | 18 Years - | Institut de Cancérologie de la Loire | |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) | NCT00500240 | Leukemia Lymphoma | Insulin Glargin... Insulin Aspart | 15 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
